BD Venture

BD Venture Limited, established in 2012 and based in Dhaka, Bangladesh, is a venture capital firm dedicated to supporting innovative startups and entrepreneurs across various sectors. It aims to promote seed, early, and growth-stage enterprises by providing investment, consultancy, and other essential services. BD Venture is particularly focused on addressing the unique challenges faced by entrepreneurs who may struggle to access traditional financing options. By leveraging the expertise of its leadership, the firm tailors its approach to meet the specific needs of each venture, fostering an environment conducive to growth and expansion.

8 past transactions

AmarSource

Venture Round in 2022
AmarSource is a research and development firm focused on addressing engineering challenges through innovative solutions. The company specializes in technology development and offers a range of services, including engineering services, repair and maintenance, industrial automation, security systems, agricultural projects, and product design. By providing these services, AmarSource aims to help businesses enhance efficiency and reduce costs, ultimately contributing to improved operational performance.

E-Desh

Series B in 2021
E-Desh is an e-commerce logistics company that specializes in providing integrated logistics solutions tailored to meet the needs of e-commerce, cross-border, and international freight forwarding enterprises. The company offers a comprehensive range of services, including first-mile pickup, last-mile delivery, fulfillment and warehousing, B2B trucking and distribution, freight forwarding, export-import services, and C2C delivery. By leveraging its expertise and technological capabilities, E-Desh enables e-commerce businesses to access efficient local and cross-border express courier services, facilitating seamless logistics operations.

Esho Shikhi

Pre Seed Round in 2019
Eshosikhi.com is an one stop online platform providing students with 360 degree solution.Students of Bangladesh can take preparation on K12 education, university entrance exam and job preparation in this platform.

Beetles Cyber Security

Seed Round in 2019
Beetles is an ISO 27001 certified cybersecurity consultancy focused on offensive security. The firm specializes in manual penetration testing assessments, simulating real-world attack scenarios on applications, APIs, network and cloud infrastructures, and devices. By employing skilled ethical hackers, Beetles offers agile and efficient Manual PenTests that can easily integrate with any development process. Additionally, the company provides PenTest-as-a-Service (PTaaS), which ensures continuous security coverage through a structured approach and collaboration with clients' internal teams. Beetles also develops tools that help organizations evaluate threats to their applications and web-facing domains, enabling them to safeguard their digital assets from potential cyber threats.

Cwork MicroJob

Pre Seed Round in 2018
Cwork MicroJob is a platform that connects businesses with a diverse, on-demand workforce for the completion of small tasks such as data collection, surveys, and content writing. The platform allows users to create a variety of tasks that can be executed via a mobile application, facilitating efficient task management. Cwork MicroJob leverages advanced technologies, including artificial intelligence and natural language processing, to enhance user engagement and optimize social media management. This approach enables businesses to expand their market reach while accessing a scalable pool of contributors, ensuring that they can meet their operational needs effectively.

Zantrik

Pre Seed Round in 2018
Zantrik Limited is a vehicle maintenance service provider based in Dhaka, Bangladesh, established in 2018. The company has developed a mobile application that streamlines vehicle maintenance by offering a range of services, including roadside assistance, mechanical repairs, car cleaning, LPG conversion, car insurance, engine servicing, cylinder re-testing, and air conditioning servicing. Zantrik aims to address the fragmented and opaque nature of traditional vehicle maintenance by creating a connected platform that enhances transparency and convenience for vehicle owners, garages, and suppliers. The platform automates the entire maintenance process, from service requests to delivery, ensuring that all stakeholders have clear visibility and can achieve value for money. By leveraging technology and artificial intelligence, Zantrik seeks to establish a scalable solution that can be expanded across different regions.

RenaMed Biologics

Venture Round in 2006
RenaMed Biologics a biotechnology company, engages in the development and commercialization of therapies for the treatment of diseases associated with compromised kidney function. The company focuses on patients suffering from acute renal failure and additional indications where kidney function is compromised. It develops RBI-01, which utilizes physiologically active human renal epithelial cells and administered ex vivo, to replace and maintain severely compromised, or lost kidney functions due to illness, or trauma. The company was founded in 1995 as Nephros Therapeutics, Inc. and changed its name to RenaMed Biologics, Inc. in 2005. RenaMed Biologics, Inc. is based in Lincoln, Rhode Island.

ViaCyte

Venture Round in 2006
ViaCyte, Inc. is a regenerative medicine company based in San Diego, California, that specializes in developing cell replacement therapies for diabetes. The company’s primary product candidates, VC-01 and VC-02, aim to treat type 1 diabetes by implanting pancreatic beta-cell precursors derived from stem cells within an encapsulation device. This innovative approach allows the implanted cells to produce insulin in response to blood glucose levels while minimizing the risk of immune rejection, thereby eliminating the need for immunosuppressants. ViaCyte's goal is to provide a long-term solution that can free both type 1 and type 2 diabetes patients from dependence on insulin and reduce associated complications such as hypoglycemia and cardiovascular issues. Founded in 1999, ViaCyte was previously known as Novocell, Inc., and changed its name in 2010. The company also operates an additional facility in Athens, Georgia.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.